top of page
BPIQ Blog
May 19, 20221 min read
Biopharma Daily Stock Updates - 05/19/22
$XBI $69.40 | +2.25% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $AKTX +7.6% Akari Therapeutics...
May 18, 20222 min read
Biopharma Daily Stock Updates - 05/18/22
$XBI $67.87 | -5.02% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $TNXP -13.1% Tonix...
May 17, 20222 min read
Biopharma Daily Stock Updates - 05/17/22
$XBI $71.46 | +4.38% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $BNTX (+5.7%) & PFE(+1.3%) Pfizer...
May 16, 20222 min read
Biopharma Daily Stock Updates - 05/16/22
$XBI $68.46 | -0.2% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $VALN -20.6% Valneva Receives...
May 13, 20221 min read
Biopharma Daily Stock Updates - 05/13/22
$XBI $68.60 | +5.68% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $NVAX +8.2% Novavax Files for...
May 12, 20222 min read
Biopharma Daily Stock Updates - 05/12/22
$XBI $64.91 | +3.34% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $MDWD +6%...
May 11, 20221 min read
Biopharma Daily Stock Updates - 05/11/22
$XBI $62.81 | -7.22% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $AKTX -5% Akari Therapeutics to...
May 10, 20222 min read
Biopharma Daily Stock Updates - 05/10/22
$XBI $67.70 | +5.17% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $FOLD +8.2%...
May 9, 20222 min read
Biopharma Daily Stock Updates - 05/09/22
$XBI $64.37 | -8.21% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $PRAX -8.5%...
May 6, 20221 min read
Biopharma Daily Stock Updates - 05/06/22
$XBI $70.13 | -5.04% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $NVAX -2.3% Novavax Submits...
May 5, 20221 min read
Biopharma Daily Stock Updates - 05/05/22
$XBI $73.85 | -6.02% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $VTGN -0.7%...
May 4, 20221 min read
Biopharma Daily Stock Updates - 05/04/22
$XBI $78.58 | +2.3% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $JAZZ +0.8%...
May 3, 20222 min read
Biopharma Daily Stock Updates - 05/03/22
$XBI $76.85 | +0.091% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $PHAT +4.8%...
May 2, 20223 min read
Biopharma Daily Stock Updates - 05/02/22
$XBI $76.78 | +4.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $SRNE +7.3% Sorrento Announces...
Apr 29, 20221 min read
Biopharma Daily Stock Updates - 04/29/22
$XBI $73.83 | -3.1% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $MRNA -5.7% Moderna Files to...
Apr 28, 20221 min read
Biopharma Daily Stock Updates - 04/28/22
$XBI $76.19| +0.36% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $MRNA +0.6% Moderna Files for...
Apr 27, 20222 min read
Biopharma Daily Stock Updates - 04/27/22
$XBI $75.92| -1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $ Pipeline Updates $SQZ -5.1% SQZ...
Apr 26, 20222 min read
Biopharma Daily Stock Updates - 04/26/22
$XBI $76.69 | -6% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates $PFE BNTX Pfizer and BioNTech Submit...
Apr 25, 20223 min read
Biopharma Daily Stock Updates - 04/25/22
$XBI $81.57 | +2.17% Covid Updates $GILD +0.64% Veklury® (Remdesivir) is First and Only Approved Treatment for Pediatric Patients Under...
Apr 22, 20221 min read
Biopharma Daily Stock Updates - 04/22/22
$XBI $79.84 | -1.63% Covid Updates $NVAX -4.4% Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page